Agenus Inc (AGEN)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

3 FORBES ROAD LEXINGTON, MA 02421

Operates as a biotechnology firm, and develops products to treat cancers, infectious diseases and autoimmune disorders. Produces some of its lead product candidates in its own manufacturing and research and development facility and contracts out other candidates.

Data as of 2021-05-08 10:21:45 -0400
Market Cap682.894 Million Shares Outstanding222.441 Million Avg 30-day Volume2.99 Million
P/E Ratio-3.77033 Dividend Yield EPS-1.05
Price/Sales7.75 Debt to Equity-1.21 EBITDA-108.835 Million
Price to Book Value-3.86 Forward PE-2.64 Enterprise Value602.735 Million
Total Cash99.871 Million Current Debt129.884 Million Gross Profit85.821 Million
BETA1.09945 52-week High/Low5.95 / 2.28 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from AGEN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 141 136 3.68% 38 (2.28%) 41 (2.55%) -7.32%
13F shares: 106.419 Million 101.789 Million 4.55% 50.268 Million 49.135 Million 2.31%
% Ownership 55.9662 53.5309 4.55% 26.436 25.8403 2.31%
New Positions: 17 24 -29.17% 4 8 -50.0%
Increased Positions 48 51 -5.88% 16 14 14.29%
Closed Positions 12 21 -42.86% 6 12 -50.0%
Reduced Positions 37 35 5.71% 11 15 -26.67%
Total Calls 586.113 Thousand 865.446 Thousand -32.28% 136.9 Thousand 187.6 Thousand -27.03%
Total Puts 373.58 Thousand 371.091 Thousand 0.67% 117.7 Thousand 97.2 Thousand 21.09%
PUT/CALL Ratio 0.64 0.43 48.84% 0.86 0.52 65.38%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ARMEN GARO H CHAIRMAN AND CEO

  • Officer
  • Director
1,425,980 2021-05-07 30

KLASKIN CHRISTINE M PFO & PAO

  • Officer
88,611 2021-04-02 3

BUELL JENNIFER PRESIDENT & COO

  • Officer
116,494 2021-04-02 3

JORDAN WADIH

  • Director
188,135 2021-04-01 6

WRIGHT TIMOTHY

  • Director
128,474 2021-04-01 7

WIINBERG ULF

  • Director
110,099 2021-04-01 7

CLARK PAUL N

  • Director
5,093 2021-04-01 4

HIRSCH SUSAN B

  • Director
8,729 2021-04-01 5

O'DAY STEVEN J CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-10 1

CORVESE BRIAN

  • Director
0 2020-12-17 3

KEARNS EVAN VP AND GENERAL COUNSEL

  • Officer
0 2020-12-17 1

JEYNES-ELLIS ALLISON M

  • Director
0 2020-12-17 3

KRAUSS ADAM CHIEF LEGAL OFFICER

  • Officer
0 2020-12-17 2

INCYTE CORP

  • 10% Owner
16,972,968 2020-06-16 2

DUNCAN ALEX CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-07-23 0

CORTIS CHRISTIAN CHIEF STRATEGY OFFICER

  • Officer
0 2019-07-23 0

VALENTINE KAREN CHIEF LEGAL OFFICER AND GC

  • Officer
0 2018-06-20 0

BAYSAL OZER CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-06-20 0

SHARP SHALINI

  • Director
0 2018-03-02 0

STEIN ROBERT BENJAMIN PRESIDENT R&D

  • Officer
No longer subject to file 2017-03-31 0

CUILLEROT JEAN-MARIE CHIEF MEDICAL OFFICER

  • Officer
0 2017-03-31 0

MALIK SHAHZAD

  • Director
0 2016-06-15 0

BALLANTYNE CHARLES EVAN CFO

  • Officer
0 2016-06-14 0

DECHAENE TOM

  • Director
No longer subject to file 2016-01-04 0

QVT ASSOCIATES GP LLC

QVT FUND V LP

  • 10% Owner
No longer subject to file 2015-01-09 0

WENTWORTH KERRY VP, CLINICAL, REG & QUAL

  • Officer
57,410 2014-02-26 0

HATSOPOULOS JOHN

  • Director
No longer subject to file 2011-12-08 0

ROTHWELL TIMOTHY G

  • Director
No longer subject to file 2011-12-08 0

LEVITSKY HYAM

  • Director
No longer subject to file 2011-08-28 0

MARGARET EISEN

  • Director
No longer subject to file 2009-06-11 0

THORNTON PETER

  • Director
0 2008-06-05 0

INVUS PUBLIC EQUITIES, LP

INVUS PUBLIC EQUITIES ADVISORS, LLC

ULYS, LLC

DEBBANE RAYMOND

  • 10% Owner
3,533,333 2008-05-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

2021-05-07 18:05:47 -0400 2021-05-07 A 4,817 $3.07 a 600,011 direct

ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

2021-04-23 18:34:35 -0400 2021-04-23 A 4,849 $3.05 a 595,194 direct -0.6369 -2.8662 0.3185 3 -2.8662 6

ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

2021-04-09 17:07:00 -0400 2021-04-09 A 4,645 $2.79 a 590,345 direct 1.3084 -4.2991 1.3084 2 -4.2991 6

ARMEN GARO H - Director - Officer CHAIRMAN & CEO

2021-04-05 09:00:33 -0400 2021-04-02 A 135,778 $2.87 a 585,700 direct -4.9342 -12.0066 0.0 1 -12.0066 6

BUELL JENNIFER - Officer PRESIDENT & COO

2021-04-05 09:06:11 -0400 2021-04-02 A 80,838 $2.87 a 116,494 direct -4.9342 -12.0066 0.0 1 -12.0066 6

KLASKIN CHRISTINE M - Officer PFO & PAO

2021-04-05 09:01:03 -0400 2021-04-02 A 24,278 $2.87 a 88,611 direct -4.9342 -12.0066 0.0 1 -12.0066 6

WRIGHT TIMOTHY - Director

2021-04-05 18:40:08 -0400 2021-04-01 A 2,546 a 128,474 direct

CLARK PAUL N - Director

2021-04-05 17:45:06 -0400 2021-04-01 A 5,093 a 5,093 direct

WIINBERG ULF - Director

2021-04-05 18:22:15 -0400 2021-04-01 A 6,960 a 110,099 direct

HIRSCH SUSAN B - Director

2021-04-05 18:56:17 -0400 2021-04-01 A 5,092 a 8,729 direct -3.1142 -6.2284 0.0 1 -7.4394 5

JORDAN WADIH - Director

2021-04-05 18:04:41 -0400 2021-04-01 A 7,130 a 188,135 direct

ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

2021-03-29 17:36:42 -0400 2021-03-26 A 4,177 $2.85 a 449,922 direct 0.7407 3.7037 12.5926 4 0.0 1

ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

2021-03-12 18:28:54 -0500 2021-03-12 A 3,428 $3.31 a 445,745 direct -5.5882 -6.1765 -8.2353 0.0 1 -24.7059 25

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AGENUS INC AGEN 2021-05-11 22:15:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 21:45:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 21:15:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 20:45:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 20:15:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 19:45:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 19:15:02 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 18:45:02 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 18:15:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 17:45:03 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 17:15:04 UTC -0.4169 0.4669 900000
AGENUS INC AGEN 2021-05-11 16:45:04 UTC -0.4122 0.4622 900000
AGENUS INC AGEN 2021-05-11 16:15:04 UTC -0.4122 0.4622 900000
AGENUS INC AGEN 2021-05-11 15:45:03 UTC -0.4122 0.4622 900000
AGENUS INC AGEN 2021-05-11 15:15:03 UTC -0.4122 0.4622 900000
AGENUS INC AGEN 2021-05-11 14:45:03 UTC -0.3663 0.4163 950000
AGENUS INC AGEN 2021-05-11 14:15:03 UTC -0.3663 0.4163 900000
AGENUS INC AGEN 2021-05-11 13:45:04 UTC -0.3663 0.4163 900000
AGENUS INC AGEN 2021-05-11 13:15:04 UTC -0.3663 0.4163 950000
AGENUS INC AGEN 2021-05-11 12:45:03 UTC -0.3663 0.4163 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio AGEN -19900.0 shares, $-63282.0 2020-12-31 N-PORT

Elevate your investments